Long‐acting antipsychotics and mortality in patients with schizophrenia receiving homecare case management

Documenti analoghi

• Risk of post‐ COVID ‐19 mental and physical health outcomes among SARS ‐ CoV ‐2‐immunologically naïve people
  di: Pao‐Huan Chen, et al.
  Pubblicazione: (2025)
• A case of marked improvement in pareidolia in untreated schizophrenia following antipsychotic treatment
  di: Tomonobu Kato, et al.
  Pubblicazione: (2026)
• Catatonia and elevated mortality: A population‐wide cohort study with healthy, sibling, and schizophrenia spectrum controls
  di: Chih‐Wei Hsu, et al.
  Pubblicazione: (2025)
• Acceptability of antipsychotic transdermal patch for acute schizophrenia: a systematic review and meta‐analysis
  di: Taro Kishi, et al.
  Pubblicazione: (2024)
• Long‐term outcomes of schizophrenia in relation to course of social recovery and prescribed antipsychotics: A 10‐year follow‐up study at a single university hospital in Japan
  di: Yuhei Mori, et al.
  Pubblicazione: (2025)